Skip to main content
Translational Psychiatry logoLink to Translational Psychiatry
. 2021 Sep 1;11:446. doi: 10.1038/s41398-021-01449-w

Correction: A randomised clinical trial of methotrexate points to possible efficacy and adaptive immune dysfunction in psychosis

I B Chaudhry 1,2,3,#, M O Husain 4,5,6,✉,#, A B Khoso 6, M I Husain 4,5, M H Buch 7,8, T Kiran 6, B Fu 9, P Bassett 10, I Qurashi 11, R ur Rahman 2, S Baig 12, A Kazmi 13, F Corsi-Zuelli 14, P M Haddad 15, B Deakin 1, N Husain 11
PMCID: PMC8410772  PMID: 34471101

Correction to: Translational Psychiatry

10.1038/s41398-020-01095-8 published online 30 November 2020

The original version of this article unfortunately contained an error in the COI section. Unfortunately, P. M. Haddad’s COI statement was missed in the PDF although it was provided by the author. We apologize for this error. P. M. Haddad’s COI statement should be: PMH has received personal fees from Janssen, Lundbeck, NewBridge Pharmaceuticals, Otsuka, and Sunovion outside the submitted work.


Articles from Translational Psychiatry are provided here courtesy of Nature Publishing Group

RESOURCES